Cargando…
An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC di...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elmer Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822660/ https://www.ncbi.nlm.nih.gov/pubmed/36660470 http://dx.doi.org/10.14740/gr1573 |
_version_ | 1784865997688143872 |
---|---|
author | Wong, Robert J. Jayasekera, Channa Jones, Patricia Kanwal, Fasiha Singal, Amit G. Ahmed, Aijaz Taglienti, Robert Younossi, Zobair Kulik, Laura Mehta, Neil |
author_facet | Wong, Robert J. Jayasekera, Channa Jones, Patricia Kanwal, Fasiha Singal, Amit G. Ahmed, Aijaz Taglienti, Robert Younossi, Zobair Kulik, Laura Mehta, Neil |
author_sort | Wong, Robert J. |
collection | PubMed |
description | Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC diagnosis reflects sub-optimal implementation of effective HCC surveillance, whereas inappropriate treatment triage or linkage to care accounts for the non-receipt of curative-intent in close to half of early-stage HCC in the USA. A free, open-access decision-support tool for liver lesions that incorporates current guideline recommendations in a user-friendly interface could improve appropriate and timely triage of patients to appropriate care. This review provides a summary of gaps and disparities in linkage to HCC care and introduces a free, internet-based, interactive decision-support tool for managing liver lesions. This tool has been developed by the HCC Steering Committee of the Chronic Liver Disease Foundation and is targeted toward clinicians across specialties who may encounter liver lesions during routine care or as part of dedicated HCC surveillance. |
format | Online Article Text |
id | pubmed-9822660 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elmer Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-98226602023-01-18 An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma Wong, Robert J. Jayasekera, Channa Jones, Patricia Kanwal, Fasiha Singal, Amit G. Ahmed, Aijaz Taglienti, Robert Younossi, Zobair Kulik, Laura Mehta, Neil Gastroenterology Res Review Hepatocellular carcinoma (HCC) is increasing in incidence and is a leading cause of cancer-related mortality worldwide. Adherence to HCC surveillance guidelines and appropriate treatment triage of liver lesions may improve receipt of curative-intent treatment and improved survival. Late-stage HCC diagnosis reflects sub-optimal implementation of effective HCC surveillance, whereas inappropriate treatment triage or linkage to care accounts for the non-receipt of curative-intent in close to half of early-stage HCC in the USA. A free, open-access decision-support tool for liver lesions that incorporates current guideline recommendations in a user-friendly interface could improve appropriate and timely triage of patients to appropriate care. This review provides a summary of gaps and disparities in linkage to HCC care and introduces a free, internet-based, interactive decision-support tool for managing liver lesions. This tool has been developed by the HCC Steering Committee of the Chronic Liver Disease Foundation and is targeted toward clinicians across specialties who may encounter liver lesions during routine care or as part of dedicated HCC surveillance. Elmer Press 2022-12 2022-12-01 /pmc/articles/PMC9822660/ /pubmed/36660470 http://dx.doi.org/10.14740/gr1573 Text en Copyright 2022, Wong et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Wong, Robert J. Jayasekera, Channa Jones, Patricia Kanwal, Fasiha Singal, Amit G. Ahmed, Aijaz Taglienti, Robert Younossi, Zobair Kulik, Laura Mehta, Neil An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
title | An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
title_full | An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
title_fullStr | An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
title_full_unstemmed | An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
title_short | An Open-Access, Interactive Decision-Support Tool to Facilitate Guideline-Driven Care for Hepatocellular Carcinoma |
title_sort | open-access, interactive decision-support tool to facilitate guideline-driven care for hepatocellular carcinoma |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9822660/ https://www.ncbi.nlm.nih.gov/pubmed/36660470 http://dx.doi.org/10.14740/gr1573 |
work_keys_str_mv | AT wongrobertj anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT jayasekerachanna anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT jonespatricia anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT kanwalfasiha anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT singalamitg anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT ahmedaijaz anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT taglientirobert anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT younossizobair anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT kuliklaura anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT mehtaneil anopenaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT wongrobertj openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT jayasekerachanna openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT jonespatricia openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT kanwalfasiha openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT singalamitg openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT ahmedaijaz openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT taglientirobert openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT younossizobair openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT kuliklaura openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma AT mehtaneil openaccessinteractivedecisionsupporttooltofacilitateguidelinedrivencareforhepatocellularcarcinoma |